Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-172

Possibly. Alternatively they had previously advised that they’d have results (or an update I’ve forgotten) by end of September. So maybe they have preliminary information back from the analysis, enough to make the announcement just given, but can’t provide the final details until analysis complete and confirmed. Previously they have also said that potential partners need to see trial results - will be interesting to see how much of the increased confidence of the initial announcement translates into SP gain prior to next announcement. If MM is talking at conference at end of October, I guess that could be a great venue to bring the analysis results to the scientific world - will that bring about a trading halt prior to conference?